BioCentury | Jun 22, 2015
Company News

OmniSeq, Roswell Park Cancer Institute diagnostic, functional genomics news

...commercializing its OmniSeq Precision Medical Technology suite of genomic diagnostics. The suite includes three components: OmniSeq...
...sequencing and a proprietary algorithm, which will initially focus on non-small cell lung cancer (NSCLC); OmniSeq...
...is a web-based IT solution that connects physicians to a patient’s electronic medical records; and OmniSeq...
BioCentury | Jul 28, 2014
Clinical News

OmniSeq Target regulatory update

...Roswell Park said the New York State Department of Health approved the company’s OmniSeq Target test...
...KRAS) and neuroblastoma Ras viral (v-Ras) oncogene (NRAS) . The cancer institute plans to incorporate OmniSeq...
...the care of “many” patients this quarter. Roswell Park Cancer Institute , Buffalo, N.Y. Product: OmniSeq...
Items per page:
1 - 2 of 2
BioCentury | Jun 22, 2015
Company News

OmniSeq, Roswell Park Cancer Institute diagnostic, functional genomics news

...commercializing its OmniSeq Precision Medical Technology suite of genomic diagnostics. The suite includes three components: OmniSeq...
...sequencing and a proprietary algorithm, which will initially focus on non-small cell lung cancer (NSCLC); OmniSeq...
...is a web-based IT solution that connects physicians to a patient’s electronic medical records; and OmniSeq...
BioCentury | Jul 28, 2014
Clinical News

OmniSeq Target regulatory update

...Roswell Park said the New York State Department of Health approved the company’s OmniSeq Target test...
...KRAS) and neuroblastoma Ras viral (v-Ras) oncogene (NRAS) . The cancer institute plans to incorporate OmniSeq...
...the care of “many” patients this quarter. Roswell Park Cancer Institute , Buffalo, N.Y. Product: OmniSeq...
Items per page:
1 - 2 of 2